Induction of Th1 immune responses to Japanese cedar pollen allergen (Cry j 1) in mice immunized with Cry j 1 conjugated with CpG oligodeoxynucleotide

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 34, Issue 2, 2011, Pages 157-161

  Kaburaki, Y ^a   Fujimura, T ^b   Kurata, K ^c   Masuda, K ^d   Toda, M ^e   Yasueda, H ^f   Chida, K ^a   Kawarai, S ^g   Sakaguchi, M ^g  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c Institute of Tokyo Environmental Allergy   (Japan)

^d Animal Allergy Clinical Laboratories   (Japan)

^e PAUL EHRLICH INSTITUT   (Germany)

^f SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^g AZABU UNIVERSITY   (Japan)

Author keywords

Allergens; CpG; IgE; Pollen

Indexed keywords

ALUMINUM HYDROXIDE; CPG OLIGODEOXYNUCLEOTIDE; CRY J 1 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CONJUGATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; JAPANESE CEDAR; MOUSE; NONHUMAN; SPLEEN CELL; TH1 CELL;

ANIMALS; ANTIGENS, PLANT; CROSS REACTIONS; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-12 SUBUNIT P40; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; PLANT PROTEINS; SPLEEN; TH1 CELLS; TH2 CELLS;

CRYPTOMERIA JAPONICA; MUS; RHODOCOCCUS RHODOCHROUS;

EID: 79951771386     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2010.06.005     Document Type: Article

References (26)

1. Okuda M. Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asth Immunol 2003, 91:288-296.
2. Yasueda H., Yui Y., Shimizu T., Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J Allergy Clin Immunol 1983, 71:77-86.
3. Sakaguchi M., Inouye S., Taniai M., Ando S., Usui M., Matuhasi T. Identification of the second major allergen of Japanese cedar pollen. Allergy 1990, 45:309-312.
4. Hashimoto M., Nigi H., Sakaguchi M., Inouye S., Imaoka K., Miyazawa H., et al. Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis. Clin Exp Allergy 1995, 25:848-852.
5. Hirahara K., Tatuta T., Takatori T., Ohtsuki M., Kirinaka H., Kawaguchi J., et al. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens. J Allergy Clin Immunol 2001, 108:94-100.
6. Fujimura T., Futamura N., Midoro-Horiuti T., Togawa A., Goldblum R.M., Yasueda H., et al. Isolation and characterization of native Cry j 3 from Japanese cedar (Cryptomeria japonica) pollen. Allergy 2007, 62:547-553.
7. Sun S., Kishimoto H., Sprent J. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med 1998, 187:1145-1150.
8. Wagner H. Toll meets bacterial CpG-DNA. Immunity 2001, 14:499-502.
9. Tighe H., Takabayashi K., Schwartz D., Van Nest G., Tuck S., Eiden J.J., et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000, 106:124-134.
10. Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa Y., et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 1984, 72:955-962.
11. Yamamoto S., Kuramoto E., Shimada S., Tokunaga T. In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 1988, 79:866-873.
12. Creticos P.S., Schroeder J.T., Hamilton R.G., Balcer-Whaley S.L., Khattignavong A.P., Lindblad R., et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. New Eng J Med 2006, 355:1445-1455.
13. Horner A.A., Takabayashi K., Beck L., Sharma B., Zubeldia J., Baird S., et al. Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity. J Allergy Clin Immunol 2002, 110:413-420.
14. Suzuki M., Ohta N., Min W.P., Matsumoto T., Min R., Zhang X., et al. Immunotherapy with CpG DNA conjugated with T-cell epitope peptide of an allergenic Cry j 2 protein is useful for control of allergic condition in mice. Ont Immunopharmacol 2007, 7:46-54.
15. Kawashima T., Taniai M., Taniguchi Y., Usui M., Ando S., Kurimoto M., et al. Antigenic analyses of Sugi basic protein by monoclonal antibodies: I. Distribution and characterization of B-cell-tropic epitopes of Cry j I molecules. Int Arch Allergy Immunol 1992, 98:110-117.
16. Kawashima T., Taniai M., Usui M., Ando S., Kurimoto M., Matuhasi T. Antigenic analyses of Sugi basic protein by monoclonal antibodies: II. Detection of immunoreactive fragments in enzyme-cleaved Cry j I. Int Arch Allergy Immunol 1992, 98:118-126.
17. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.D., Sato Y., Ronaghy A., et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997, 3:849-854.
18. Marshall J.D., Abtahi S., Eiden J.J., Tuck S., Milley R., Haycock F., et al. Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 2001, 108:191-197.
19. Tighe H., Takabayashi K., Schwartz D., Van Nest G., Tuck S., Eiden J.J., et al. Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity. Eur J Immunol 2000, 30:1939-1947.
20. Toda M., Sato H., Takebe Y., Taniguchi Y., Saito S., Inouye S., et al. Inhibition of immunoglobulin E response to Japanese cedar pollen allergen (Cry j 1) in mice by DNA immunization: different outcomes dependent on the plasmid DNA inoculation method. Immunology 2000, 99:179-186.
21. Sakaguchi M., Toda M., Ebihara T., Irie S., Hori H., Imai A., et al. IgE antibody to fish gelatin (type I collagen) in patients with fish allergy. J Allergy Clin Immunol 2000, 106:579-584.
22. Toda M., Kasai M., Hosokawa H., Nakano N., Taniguchi Y., Inouye S., et al. DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response. Eur J Immunol 2002, 32:1631-1639.
23. Finkelman F.D., Katona I.M., Mosmann T.R., Coffman R.L. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988, 140:1022-1027.
24. Iho S., Yamamoto T., Takahashi T., Yamamoto S. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro. J Immunol 1999, 163:3642-3652.
25. Brewer J.M., Conacher M., Satoskar A., Bluethmann H., Alexander J. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur J Immunol 1996, 26:2062-2066.
26. Brewer J.M., Conacher M., Hunter C.A., Mohrs M., Brombacher F., Alexander J. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol 1999, 163:6448-6454.